Santhera Pharmaceuticals Holding AG
SANN
Peringkat dalam Saham
#16256
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Harga Saham
$18.83
Kapitalisasi Pasar
$288.17M
Perubahan (1 hari)
0.42%
Perubahan (1 tahun)
44.89%
Negara
CH
Perdagangan Santhera Pharmaceuticals Holding AG (SANN)
Kategori
Healthcare
Kapitalisasi pasar dari Santhera Pharmaceuticals Holding AG(SANN)
Kapitalisasi Pasar: $288.17M
Per October 2026, Santhera Pharmaceuticals Holding AG memiliki kapitalisasi pasar sebesar $288.17M. Ini menjadikan Santhera Pharmaceuticals Holding AG sebagai perusahaan 16256th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Santhera Pharmaceuticals Holding AG dari 2014 hingga 2026
SANN dibandingkan dengan 5 teratas stocks paling populer
